产品描述
| 溶解性 |
|
| 存贮条件 | 储存温度-20°C |
| 应用 | A potent inhibitor of Polo-like kinase and a broad-spectrum anti-tumor agent |
| 产品介绍 | HMN-214(IVX214)是PLK1抑制剂，平均IC50为0.12 μM。 |
| 生化机理 | HMN-214 (IVX-214) is a potent inhibitor of Polo-like kinase (Plk) with IC50 of 118 nM. HMN-214 shows potent and broad-spectrum anti-tumor activity against various cancer cells, including HeLa, PC-3, DU-145, MIAPaCa-2, U937, MCF-7, A549, and WiDr, with a mean IC50 value of 118 nM. HMN-176 is also cytotoxic to drug-resistant human and murine cell lines, including P388/CDDP, P388/VCR, K2/CDDP, and K2/VP-16, with IC50 values ranging from 143 nM–265 nM. In HeLa cells, HMN-176 (3 μM) blocks cell cycle at G2/M phase. HMN-176 (3 μM) down-regulates the expression of the multi-drug resistance gene (MDR1), due to the disturbance of NF-Y transcription factor binding to the MDR1 promoter. HMN-176 (250 nM–2.5 μM) inhibits meiotic spindle assembly and aster formation of Spisula oocytes. HMN-176 (2.5 μM) also inhibits aster microtubule formation from human centrosomes. |
| 别名 | HMN214;HMN 214; (E)-4-(2-(2-(N-乙酰基-N-((4-甲氧基苯基)磺酰)氨基)苯基)乙烯基)吡啶 1-氧化物;;IVX-214;IVX 214;IVX-214;IVX214;(e)-4-(2-(2-(n-acetyl-n-((4-methoxyphenyl)sulfonyl)amino)phenyl)ethenyl)pyridine 1-oxide |
